这是一篇来自已证抗体库的有关人类 ALCAM的综述,是根据76篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合ALCAM 抗体。
ALCAM 同义词: CD166; MEMD

圣克鲁斯生物技术
小鼠 单克隆(B-6)
  • 免疫印迹; 人类; 图 2c
圣克鲁斯生物技术 ALCAM抗体(Santa Cruz Biotechnology, sc-74558)被用于被用于免疫印迹在人类样本上 (图 2c). Aging (Albany NY) (2020) ncbi
小鼠 单克隆(B-6)
  • 免疫细胞化学; 人类; 图 1a
圣克鲁斯生物技术 ALCAM抗体(Santa Cruz, sc-74558)被用于被用于免疫细胞化学在人类样本上 (图 1a). Adipocyte (2019) ncbi
  • 免疫印迹; 人类; 图 4f
圣克鲁斯生物技术 ALCAM抗体(Santa Cruz, H-108)被用于被用于免疫印迹在人类样本上 (图 4f). Oncogenesis (2016) ncbi
  • 免疫印迹; 人类; 图 3C
圣克鲁斯生物技术 ALCAM抗体(Santa cruz, H-108)被用于被用于免疫印迹在人类样本上 (图 3C). Mol Cell Biol (2015) ncbi
小鼠 单克隆(H-9)
  • 免疫细胞化学; 人类
圣克鲁斯生物技术 ALCAM抗体(Santa Cruz Biotechnology, sc-74557)被用于被用于免疫细胞化学在人类样本上. Cell Signal (2015) ncbi
  • 免疫印迹; 人类; 1:1000; 图 6g
圣克鲁斯生物技术 ALCAM抗体(Santa Cruz, H-108)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6g). Mol Cancer (2015) ncbi
  • 免疫细胞化学; 人类; 1:100; 表 1
圣克鲁斯生物技术 ALCAM抗体(Santa Cruz, sc25624)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (表 1). Acta Biomater (2015) ncbi
  • 免疫细胞化学; 人类; 图 2a
  • 免疫印迹; 人类; 图 3a
圣克鲁斯生物技术 ALCAM抗体(Santa Cruz Biotechnology, H-108)被用于被用于免疫细胞化学在人类样本上 (图 2a) 和 被用于免疫印迹在人类样本上 (图 3a). Mol Biol Cell (2014) ncbi
小鼠 单克隆(H-9)
  • 免疫印迹; 人类
圣克鲁斯生物技术 ALCAM抗体(Santa Cruz Biotechnology, SC-74557)被用于被用于免疫印迹在人类样本上. Biochem Biophys Res Commun (2014) ncbi
艾博抗(上海)贸易有限公司
小鼠 单克隆(3D9F1)
  • 免疫组化; 人类; 1:100; 图 6d
艾博抗(上海)贸易有限公司 ALCAM抗体(Abcam, ab233750)被用于被用于免疫组化在人类样本上浓度为1:100 (图 6d). Front Cell Dev Biol (2021) ncbi
  • 免疫细胞化学; 家羊; 图 4
艾博抗(上海)贸易有限公司 ALCAM抗体(abcam, ab78649)被用于被用于免疫细胞化学在家羊样本上 (图 4). Cell Tissue Bank (2016) ncbi
domestic rabbit 单克隆(EPR2759(2))
  • 免疫印迹; 人类; 图 1
艾博抗(上海)贸易有限公司 ALCAM抗体(Epitomics, 3133)被用于被用于免疫印迹在人类样本上 (图 1). Oncotarget (2015) ncbi
domestic rabbit 单克隆(EPR2759(2))
  • 免疫组化; 人类
  • 免疫印迹; 人类
艾博抗(上海)贸易有限公司 ALCAM抗体(Epitomics, 3133)被用于被用于免疫组化在人类样本上 和 被用于免疫印迹在人类样本上. Cell Signal (2015) ncbi
domestic rabbit 单克隆(EPR2759(2))
  • 免疫印迹; 人类; 图 4c
艾博抗(上海)贸易有限公司 ALCAM抗体(Abcam, ab109215)被用于被用于免疫印迹在人类样本上 (图 4c). Mol Carcinog (2015) ncbi
domestic rabbit 单克隆(EPR2759(2))
  • 免疫印迹; 人类
艾博抗(上海)贸易有限公司 ALCAM抗体(Epitomics, 3133)被用于被用于免疫印迹在人类样本上. Biochem Biophys Res Commun (2014) ncbi
伯乐(Bio-Rad)公司
小鼠 单克隆(3A6)
  • 流式细胞仪; 人类; 1:50; 图 3a, 3b
伯乐(Bio-Rad)公司 ALCAM抗体(ABD Serotec, MCA1926A488T)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 3a, 3b). Stem Cells (2019) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 人类; 1:20; 图 2a
伯乐(Bio-Rad)公司 ALCAM抗体(AbD Serotec, MCA1926A488)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 2a). Nat Commun (2015) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 人类; 图 2
伯乐(Bio-Rad)公司 ALCAM抗体(AbD Serotec, MCA1926F)被用于被用于流式细胞仪在人类样本上 (图 2). PLoS ONE (2015) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 人类; 1:50
伯乐(Bio-Rad)公司 ALCAM抗体(AbD Serotec, MCA1926F)被用于被用于流式细胞仪在人类样本上浓度为1:50. Int J Mol Med (2012) ncbi
BioLegend
小鼠 单克隆(3A6)
  • 流式细胞仪; 人类; 1:80; 图 10
BioLegend ALCAM抗体(Biolegend, 343904)被用于被用于流式细胞仪在人类样本上浓度为1:80 (图 10). elife (2017) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 人类; 图 4a
  • 免疫细胞化学; 人类; 图 4g
BioLegend ALCAM抗体(BioLegend, 3A6)被用于被用于流式细胞仪在人类样本上 (图 4a) 和 被用于免疫细胞化学在人类样本上 (图 4g). Nat Genet (2017) ncbi
小鼠 单克隆(3A6)
  • 免疫细胞化学; 人类; 1:50; 图 1c
BioLegend ALCAM抗体(BioLegend, 343902)被用于被用于免疫细胞化学在人类样本上浓度为1:50 (图 1c). Nat Commun (2015) ncbi
小鼠 单克隆(3A6)
  • 免疫细胞化学; 家羊; 图 5
BioLegend ALCAM抗体(Biolegend, 3A6)被用于被用于免疫细胞化学在家羊样本上 (图 5). J Tissue Eng Regen Med (2016) ncbi
赛默飞世尔
小鼠 单克隆(3A6)
  • 流式细胞仪; 小鼠; 图 3d
赛默飞世尔 ALCAM抗体(eBioscience, 12-1668)被用于被用于流式细胞仪在小鼠样本上 (图 3d). Cell Rep (2018) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 ALCAM抗体(BD, 46166842)被用于被用于流式细胞仪在人类样本上 (图 1a). Cell Death Dis (2016) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 ALCAM抗体(eBioscience, 3A6)被用于被用于流式细胞仪在人类样本上 (图 4). Sci Rep (2016) ncbi
安迪生物R&D
domestic goat 多克隆
  • 免疫组化基因敲除验证; 小鼠; 1:50; 图 s1c
安迪生物R&D ALCAM抗体(R&D Systems, AF1172)被用于被用于免疫组化基因敲除验证在小鼠样本上浓度为1:50 (图 s1c). Development (2021) ncbi
赛信通(上海)生物试剂有限公司
小鼠 单克隆(TRA-1-81)
  • 免疫细胞化学; 人类; 1:400; 图 5
赛信通(上海)生物试剂有限公司 ALCAM抗体(Cell Signaling, TRA-1-81)被用于被用于免疫细胞化学在人类样本上浓度为1:400 (图 5). Nat Med (2016) ncbi
小鼠 单克隆(TRA-1-81)
  • 免疫细胞化学; 人类; 1:800; 表 s1
赛信通(上海)生物试剂有限公司 ALCAM抗体(Cell Signaling, 4745)被用于被用于免疫细胞化学在人类样本上浓度为1:800 (表 s1). J Chin Med Assoc (2015) ncbi
小鼠 单克隆(TRA-1-81)
  • 免疫细胞化学; pigs ; 图 1
赛信通(上海)生物试剂有限公司 ALCAM抗体(Cell Signaling, 4745P)被用于被用于免疫细胞化学在pigs 样本上 (图 1). PLoS ONE (2015) ncbi
小鼠 单克隆(TRA-1-81)
  • 免疫细胞化学; 人类; 1:200
赛信通(上海)生物试剂有限公司 ALCAM抗体(Cell Signaling, 4745)被用于被用于免疫细胞化学在人类样本上浓度为1:200. PLoS ONE (2014) ncbi
小鼠 单克隆(TRA-1-81)
  • 免疫细胞化学; 人类; 1:800
赛信通(上海)生物试剂有限公司 ALCAM抗体(Cell signaling, 4745)被用于被用于免疫细胞化学在人类样本上浓度为1:800. Front Aging Neurosci (2014) ncbi
Stemcell Technologies
  • 流式细胞仪; 人类
  • 免疫细胞化学; 人类; 1:300
干细胞技术 ALCAM抗体(STEMCELL技术, 01556)被用于被用于流式细胞仪在人类样本上 和 被用于免疫细胞化学在人类样本上浓度为1:300. Acta Naturae (2014) ncbi
碧迪BD
小鼠 单克隆(TRA-1-60)
  • 免疫组化; 小鼠; 1:1000
碧迪BD ALCAM抗体(BD Pharmingen, 560380)被用于被用于免疫组化在小鼠样本上浓度为1:1000. Nat Commun (2021) ncbi
小鼠 单克隆(KS1/4)
  • 流式细胞仪; 人类; 1:200; 图 2g
碧迪BD ALCAM抗体(BD Biosciences, KS1/4)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 2g). Nature (2021) ncbi
小鼠 单克隆(TRA-1-60)
  • 流式细胞仪; 人类; 1:15; 图 s5e
碧迪BD ALCAM抗体(BD Bioscience, 560884)被用于被用于流式细胞仪在人类样本上浓度为1:15 (图 s5e). Cell Death Dis (2020) ncbi
小鼠 单克隆(TRA-1-60)
  • 流式细胞仪; 人类; 图 s3c
碧迪BD ALCAM抗体(BD Biosciences, 560380)被用于被用于流式细胞仪在人类样本上 (图 s3c). Haematologica (2019) ncbi
小鼠 单克隆(3A6)
  • 免疫细胞化学; 人类; 图 s1a
碧迪BD ALCAM抗体(BD Biosciences, 560903)被用于被用于免疫细胞化学在人类样本上 (图 s1a). Cell (2019) ncbi
小鼠 单克隆(TRA-1-60)
  • 流式细胞仪; 人类; 图 s1d
碧迪BD ALCAM抗体(BD Biosciences, 560884)被用于被用于流式细胞仪在人类样本上 (图 s1d). Cell Rep (2019) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 人类; 1:100; 图 3a
碧迪BD ALCAM抗体(BD, 559263)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 3a). Sci Rep (2018) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 人类; 图 s4c
碧迪BD ALCAM抗体(BD Pharmingen, 559263)被用于被用于流式细胞仪在人类样本上 (图 s4c). Hum Mol Genet (2017) ncbi
小鼠 单克隆(TRA-1-81)
  • 免疫细胞化学; domestic goat; 1:500; 图 3A
碧迪BD ALCAM抗体(BD, 560072)被用于被用于免疫细胞化学在domestic goat样本上浓度为1:500 (图 3A). BMC Biotechnol (2017) ncbi
小鼠 单克隆(TRA-1-60)
  • 免疫细胞化学; domestic goat; 1:500; 图 3A
碧迪BD ALCAM抗体(BD, 560884)被用于被用于免疫细胞化学在domestic goat样本上浓度为1:500 (图 3A). BMC Biotechnol (2017) ncbi
小鼠 单克隆(TRA-1-60)
  • 流式细胞仪; 人类; 图 1a
碧迪BD ALCAM抗体(BD Biosciences, 560380)被用于被用于流式细胞仪在人类样本上 (图 1a). PLoS ONE (2017) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 人类; 1:50; 图 st2
碧迪BD ALCAM抗体(BD Biosciences, 559263)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 st2). Sci Rep (2017) ncbi
小鼠 单克隆(TRA-1-60)
  • 流式细胞仪; 人类; 图 1a
碧迪BD ALCAM抗体(BD Pharmingen, 562711)被用于被用于流式细胞仪在人类样本上 (图 1a). Biol Open (2017) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 人类; 表 3
碧迪BD ALCAM抗体(BD Pharmingen, 3A6)被用于被用于流式细胞仪在人类样本上 (表 3). Am J Pathol (2017) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 家羊
碧迪BD ALCAM抗体(BD Pharmingen, 3A6)被用于被用于流式细胞仪在家羊样本上. J Tissue Eng Regen Med (2017) ncbi
小鼠 单克隆(TRA-1-81)
  • 免疫组化; 人类; 1:200; 图 1h
碧迪BD ALCAM抗体(BD Pharmingen, 560072)被用于被用于免疫组化在人类样本上浓度为1:200 (图 1h). Stem Cell Res (2016) ncbi
小鼠 单克隆(TRA-1-60)
  • 流式细胞仪; 人类; 图 3
碧迪BD ALCAM抗体(Becton Dickinson, 563188)被用于被用于流式细胞仪在人类样本上 (图 3). Stem Cell Reports (2016) ncbi
小鼠 单克隆(TRA-1-81)
  • 流式细胞仪; 人类; 1:50; 图 2c
  • 免疫组化; 人类; 1:10; 图 2d
碧迪BD ALCAM抗体(BD Biosciences, 560174)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 2c) 和 被用于免疫组化在人类样本上浓度为1:10 (图 2d). Development (2016) ncbi
小鼠 单克隆(TRA-1-81)
  • 流式细胞仪; 人类; 图 5
碧迪BD ALCAM抗体(BD Biosciences, 560161)被用于被用于流式细胞仪在人类样本上 (图 5). PLoS ONE (2016) ncbi
小鼠 单克隆(TRA-1-60)
  • 流式细胞仪; 人类; 图 5
碧迪BD ALCAM抗体(BD Biosciences, 560193)被用于被用于流式细胞仪在人类样本上 (图 5). PLoS ONE (2016) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 人类; 图 2
碧迪BD ALCAM抗体(BD Biosciences, 559263)被用于被用于流式细胞仪在人类样本上 (图 2). Mol Med Rep (2016) ncbi
小鼠 单克隆(3A6)
  • 免疫组化; 人类; 图 4
碧迪BD ALCAM抗体(BD, 559260)被用于被用于免疫组化在人类样本上 (图 4). Sci Rep (2016) ncbi
小鼠 单克隆(TRA-1-81)
  • 流式细胞仪; 人类; 图 1
碧迪BD ALCAM抗体(Becton Dickinson, 560161)被用于被用于流式细胞仪在人类样本上 (图 1). Stem Cell Rev (2016) ncbi
小鼠 单克隆(TRA-1-60)
  • 流式细胞仪; 人类; 图 1
碧迪BD ALCAM抗体(Becton Dickinson, 560193)被用于被用于流式细胞仪在人类样本上 (图 1). Stem Cell Rev (2016) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 人类
碧迪BD ALCAM抗体(BD Bioscience, 559263)被用于被用于流式细胞仪在人类样本上. Mol Med Rep (2016) ncbi
小鼠 单克隆(TRA-1-60)
  • 流式细胞仪; 人类; 1:50; 图 s1
碧迪BD ALCAM抗体(BD Biosciences, 560173)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 s1). Nat Med (2016) ncbi
小鼠 单克隆(3A6)
  • 其他; 人类; 500 ug/ml; 图 1
碧迪BD ALCAM抗体(Becton Dickinson, 559260)被用于被用于其他在人类样本上浓度为500 ug/ml (图 1). J Extracell Vesicles (2016) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 家羊; 1:5; 图 3
碧迪BD ALCAM抗体(BD Biosciences, 559263)被用于被用于流式细胞仪在家羊样本上浓度为1:5 (图 3). Cytometry A (2016) ncbi
小鼠 单克隆(TRA-1-60)
  • 免疫细胞化学; 人类; 1:100
碧迪BD ALCAM抗体(BD, 560173)被用于被用于免疫细胞化学在人类样本上浓度为1:100. Nature (2016) ncbi
小鼠 单克隆(TRA-1-60)
  • 流式细胞仪; 人类; 图 s1
碧迪BD ALCAM抗体(BD Biosciences, 560884)被用于被用于流式细胞仪在人类样本上 (图 s1). Sci Rep (2016) ncbi
小鼠 单克隆(TRA-1-81)
  • 免疫细胞化学; 人类; 图 s1
碧迪BD ALCAM抗体(BD Biosciences, 560161)被用于被用于免疫细胞化学在人类样本上 (图 s1). Sci Rep (2016) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 人类; 图 st1
碧迪BD ALCAM抗体(BD, 559263)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(TRA-1-81)
  • 流式细胞仪; 人类; 1:10; 图 1
碧迪BD ALCAM抗体(BD, 560793)被用于被用于流式细胞仪在人类样本上浓度为1:10 (图 1). Nat Commun (2016) ncbi
小鼠 单克隆(TRA-1-60)
  • 流式细胞仪; 人类; 1:10; 图 1
碧迪BD ALCAM抗体(BD, 560380)被用于被用于流式细胞仪在人类样本上浓度为1:10 (图 1). Nat Commun (2016) ncbi
小鼠 单克隆(TRA-1-60)
  • 流式细胞仪; 小鼠; 图 5a
碧迪BD ALCAM抗体(BD Pharmingen, 560193)被用于被用于流式细胞仪在小鼠样本上 (图 5a). Stem Cells Dev (2016) ncbi
小鼠 单克隆(KS1/4)
  • 其他; 人类; 图 st1
碧迪BD ALCAM抗体(BD, KS1/4)被用于被用于其他在人类样本上 (图 st1). Mol Cell Proteomics (2016) ncbi
小鼠 单克隆(TRA-1-81)
  • 免疫细胞化学; 人类; 表 2
碧迪BD ALCAM抗体(BD Bioscience, 560885)被用于被用于免疫细胞化学在人类样本上 (表 2). Exp Cell Res (2015) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 家羊; 20 ug/ml; 图 3
碧迪BD ALCAM抗体(BD PharMigen, 559263)被用于被用于流式细胞仪在家羊样本上浓度为20 ug/ml (图 3). Cell Tissue Bank (2016) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 人类; 图 2
碧迪BD ALCAM抗体(BD Biosciences, 559263)被用于被用于流式细胞仪在人类样本上 (图 2). J Endod (2015) ncbi
小鼠 单克隆(TRA-1-60)
  • 流式细胞仪; 人类; 图 2
碧迪BD ALCAM抗体(BD Bioscience, 562711)被用于被用于流式细胞仪在人类样本上 (图 2). PLoS ONE (2015) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 人类; 图 s4
碧迪BD ALCAM抗体(BD Pharmingen, 559263)被用于被用于流式细胞仪在人类样本上 (图 s4). Stem Cell Reports (2015) ncbi
小鼠 单克隆(TRA-1-60)
  • 流式细胞仪; 人类; 图 3
碧迪BD ALCAM抗体(BD Biosciences, 560380)被用于被用于流式细胞仪在人类样本上 (图 3). Stem Cell Rev (2015) ncbi
小鼠 单克隆(3A6)
  • 免疫细胞化学; 人类
碧迪BD ALCAM抗体(BD Biosciences, 559263)被用于被用于免疫细胞化学在人类样本上. Cell (2015) ncbi
小鼠 单克隆(TRA-1-81)
  • 免疫细胞化学; 人类
碧迪BD ALCAM抗体(BD Biosciences, 560194)被用于被用于免疫细胞化学在人类样本上. Cell (2015) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 人类; 图 5
碧迪BD ALCAM抗体(BD Biosciences, 559263)被用于被用于流式细胞仪在人类样本上 (图 5). Stem Cell Reports (2015) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 家羊
碧迪BD ALCAM抗体(BD Pharmingen, 3A6)被用于被用于流式细胞仪在家羊样本上. Cytotechnology (2016) ncbi
小鼠 单克隆(TRA-1-81)
  • 免疫细胞化学; 人类; 1:500
碧迪BD ALCAM抗体(BD biosciences, 560793)被用于被用于免疫细胞化学在人类样本上浓度为1:500. Peerj (2014) ncbi
小鼠 单克隆(TRA-1-60)
  • 流式细胞仪; 人类; 图 s3a
碧迪BD ALCAM抗体(BD Biosciences, TRA-1-60)被用于被用于流式细胞仪在人类样本上 (图 s3a). Nucleic Acids Res (2015) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 人类; 1:500
碧迪BD ALCAM抗体(BD Bioscience, 559263)被用于被用于流式细胞仪在人类样本上浓度为1:500. PLoS ONE (2014) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 人类
碧迪BD ALCAM抗体(Becton Dickinson, clone 3A6)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(TRA-1-60)
  • 免疫细胞化学; 人类; 1:50
碧迪BD ALCAM抗体(BD Biosciences, 560173)被用于被用于免疫细胞化学在人类样本上浓度为1:50. Stem Cells Transl Med (2014) ncbi
小鼠 单克隆(3A6)
  • 流式细胞仪; 人类; 1 ug/1x106 cells
碧迪BD ALCAM抗体(BD pharmingen, 559260)被用于被用于流式细胞仪在人类样本上浓度为1 ug/1x106 cells. J Cell Mol Med (2014) ncbi
徕卡显微系统(上海)贸易有限公司
  • 免疫组化; 人类; 1:50; 图 1
徕卡显微系统(上海)贸易有限公司 ALCAM抗体(Novocastra, NCL-CD166)被用于被用于免疫组化在人类样本上浓度为1:50 (图 1). Nat Commun (2016) ncbi
文章列表
  1. Liu W, Brodsky A, Feng M, Liu Y, Ding J, Jayasuriya C, et al. Senescent Tissue-Resident Mesenchymal Stromal Cells Are an Internal Source of Inflammation in Human Osteoarthritic Cartilage. Front Cell Dev Biol. 2021;9:725071 pubmed 出版商
  2. Delgado C, Bu L, Zhang J, Liu F, Sall J, Liang F, et al. Neural cell adhesion molecule is required for ventricular conduction system development. Development. 2021;148: pubmed 出版商
  3. Hanna R, Flamier A, Barabino A, Bernier G. G-quadruplexes originating from evolutionary conserved L1 elements interfere with neuronal gene expression in Alzheimer's disease. Nat Commun. 2021;12:1828 pubmed 出版商
  4. Biswas S, Mandal G, Payne K, Anadon C, Gatenbee C, Chaurio R, et al. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature. 2021;591:464-470 pubmed 出版商
  5. Varela Eirin M, Carpintero Fernández P, Sánchez Temprano A, Varela Vazquez A, Paíno C, Casado Diaz A, et al. Senolytic activity of small molecular polyphenols from olive restores chondrocyte redifferentiation and promotes a pro-regenerative environment in osteoarthritis. Aging (Albany NY). 2020;12:15882-15905 pubmed 出版商
  6. Marin Navarro A, Pronk R, van der Geest A, Oliynyk G, Nordgren A, Arsenian Henriksson M, et al. p53 controls genomic stability and temporal differentiation of human neural stem cells and affects neural organization in human brain organoids. Cell Death Dis. 2020;11:52 pubmed 出版商
  7. Menon V, Thomas R, Elgueta C, Horl M, Osborn T, Hallett P, et al. Comprehensive Cell Surface Antigen Analysis Identifies Transferrin Receptor Protein-1 (CD71) as a Negative Selection Marker for Human Neuronal Cells. Stem Cells. 2019;37:1293-1306 pubmed 出版商
  8. Nasri M, Ritter M, Mir P, Dannenmann B, Aghaallaei N, Amend D, et al. CRISPR/Cas9 mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients. Haematologica. 2019;: pubmed 出版商
  9. Radhakrishnan S, Trentz O, Reddy M, Rela M, Kandasamy M, Sellathamby S. In vitro transdifferentiation of human adipose tissue-derived stem cells to neural lineage cells - a stage-specific incidence. Adipocyte. 2019;8:164-177 pubmed 出版商
  10. Nakanishi M, Mitchell R, Benoit Y, Orlando L, Reid J, Shimada K, et al. Human Pluripotency Is Initiated and Preserved by a Unique Subset of Founder Cells. Cell. 2019;177:910-924.e22 pubmed 出版商
  11. Mair B, Tomic J, Masud S, Tonge P, Weiss A, Usaj M, et al. Essential Gene Profiles for Human Pluripotent Stem Cells Identify Uncharacterized Genes and Substrate Dependencies. Cell Rep. 2019;27:599-615.e12 pubmed 出版商
  12. Barros Silva J, Linn D, Steiner I, Guo G, Ali A, Pakula H, et al. Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer. Cell Rep. 2018;25:3504-3518.e6 pubmed 出版商
  13. Paik E, O Neil A, Ng S, Sun C, Rubin L. Using intracellular markers to identify a novel set of surface markers for live cell purification from a heterogeneous hIPSC culture. Sci Rep. 2018;8:804 pubmed 出版商
  14. Miller E, Kobayashi G, Musso C, Allen M, Ishiy F, de Caires L, et al. EIF4A3 deficient human iPSCs and mouse models demonstrate neural crest defects that underlie Richieri-Costa-Pereira syndrome. Hum Mol Genet. 2017;26:2177-2191 pubmed 出版商
  15. Chen H, Zuo Q, Wang Y, Song J, Yang H, Zhang Y, et al. Inducing goat pluripotent stem cells with four transcription factor mRNAs that activate endogenous promoters. BMC Biotechnol. 2017;17:11 pubmed 出版商
  16. Fielding C, Weekes M, Nobre L, Růcková E, Wilkie G, Paulo J, et al. Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation. elife. 2017;6: pubmed 出版商
  17. Flamier A, Singh S, Rasmussen T. A standardized human embryoid body platform for the detection and analysis of teratogens. PLoS ONE. 2017;12:e0171101 pubmed 出版商
  18. Gamal W, Treskes P, Samuel K, Sullivan G, Siller R, Srsen V, et al. Low-dose acetaminophen induces early disruption of cell-cell tight junctions in human hepatic cells and mouse liver. Sci Rep. 2017;7:37541 pubmed 出版商
  19. Bharathan S, Manian K, Aalam S, Palani D, Deshpande P, Pratheesh M, et al. Systematic evaluation of markers used for the identification of human induced pluripotent stem cells. Biol Open. 2017;6:100-108 pubmed 出版商
  20. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed 出版商
  21. Park R, Wang T, Koundakjian D, Hultquist J, Lamothe Molina P, Monel B, et al. A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors. Nat Genet. 2017;49:193-203 pubmed 出版商
  22. Wu M, Tang W, Zhan X, Li Y, Peng Y, Huang X, et al. FOXK1 interaction with FHL2 promotes proliferation, invasion and metastasis in colorectal cancer. Oncogenesis. 2016;5:e271 pubmed 出版商
  23. Caminal M, Velez R, Rabanal R, Vivas D, Batlle Morera L, Aguirre M, et al. A reproducible method for the isolation and expansion of ovine mesenchymal stromal cells from bone marrow for use in regenerative medicine preclinical studies. J Tissue Eng Regen Med. 2017;11:3408-3416 pubmed 出版商
  24. Kele M, Day K, Rönnholm H, Schuster J, Dahl N, Falk A. Generation of human iPS cell line CTL07-II from human fibroblasts, under defined and xeno-free conditions. Stem Cell Res. 2016;17:474-478 pubmed 出版商
  25. Muñoz López A, Romero Moya D, Prieto C, Ramos Mejia V, Agraz Doblas A, Varela I, et al. Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency. Stem Cell Reports. 2016;7:602-618 pubmed 出版商
  26. Zimmerlin L, Park T, Huo J, Verma K, Pather S, Talbot C, et al. Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality. Development. 2016;143:4368-4380 pubmed
  27. Ahmadian Baghbaderani B, Tian X, Scotty Cadet J, Shah K, Walde A, Tran H, et al. A Newly Defined and Xeno-Free Culture Medium Supports Every-Other-Day Medium Replacement in the Generation and Long-Term Cultivation of Human Pluripotent Stem Cells. PLoS ONE. 2016;11:e0161229 pubmed 出版商
  28. Ilmer M, Mazurek N, Byrd J, Ramirez K, Hafley M, Alt E, et al. Cell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor-initiating cancer cells with heightened stem cell characteristics. Cell Death Dis. 2016;7:e2337 pubmed 出版商
  29. Jiang S, Chen G, Feng L, Jiang Z, Yu M, Bao J, et al. Disruption of kif3a results in defective osteoblastic differentiation in dental mesenchymal stem/precursor cells via the Wnt signaling pathway. Mol Med Rep. 2016;14:1891-900 pubmed 出版商
  30. Harfuddin Z, Dharmadhikari B, Wong S, Duan K, Poidinger M, Kwajah S, et al. Transcriptional and functional characterization of CD137L-dendritic cells identifies a novel dendritic cell phenotype. Sci Rep. 2016;6:29712 pubmed 出版商
  31. He Z, Forest F, Gain P, Rageade D, Bernard A, Acquart S, et al. 3D map of the human corneal endothelial cell. Sci Rep. 2016;6:29047 pubmed 出版商
  32. Zhang W, Chin T, Yang H, Nga M, Lunny D, Lim E, et al. Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression. Nat Commun. 2016;7:11702 pubmed 出版商
  33. Baghbaderani B, Syama A, Sivapatham R, Pei Y, Mukherjee O, Fellner T, et al. Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications. Stem Cell Rev. 2016;12:394-420 pubmed 出版商
  34. Wang X, Zhu Y, Xu B, Wang J, Liu X. Identification of TLR2 and TLR4?induced microRNAs in human mesenchymal stem cells and their possible roles in regulating TLR signals. Mol Med Rep. 2016;13:4969-80 pubmed 出版商
  35. Burridge P, Li Y, Matsa E, Wu H, Ong S, Sharma A, et al. Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. Nat Med. 2016;22:547-56 pubmed 出版商
  36. Belov L, Matic K, Hallal S, Best O, Mulligan S, Christopherson R. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles. 2016;5:25355 pubmed 出版商
  37. Khan M, Chandrashekran A, Smith R, Dudhia J. Immunophenotypic characterization of ovine mesenchymal stem cells. Cytometry A. 2016;89:443-50 pubmed 出版商
  38. Francis K, Ton A, Xin Y, O Halloran P, Wassif C, Malik N, et al. Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/β-catenin defects in neuronal cholesterol synthesis phenotypes. Nat Med. 2016;22:388-96 pubmed 出版商
  39. Sagi I, Chia G, Golan Lev T, Peretz M, Weissbein U, Sui L, et al. Derivation and differentiation of haploid human embryonic stem cells. Nature. 2016;532:107-11 pubmed 出版商
  40. Zou L, Chen Q, Quanbeck Z, Bechtold J, Kaufman D. Angiogenic activity mediates bone repair from human pluripotent stem cell-derived osteogenic cells. Sci Rep. 2016;6:22868 pubmed 出版商
  41. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  42. Sancho Martinez I, Nivet E, Xia Y, Hishida T, Aguirre A, Ocampo A, et al. Establishment of human iPSC-based models for the study and targeting of glioma initiating cells. Nat Commun. 2016;7:10743 pubmed 出版商
  43. Kang L, Yao C, Khodadadi Jamayran A, Xu W, Zhang R, Banerjee N, et al. The Universal 3D3 Antibody of Human PODXL Is Pluripotent Cytotoxic, and Identifies a Residual Population After Extended Differentiation of Pluripotent Stem Cells. Stem Cells Dev. 2016;25:556-68 pubmed 出版商
  44. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed 出版商
  45. Fridriksdottir A, Kim J, Villadsen R, Klitgaard M, Hopkinson B, Petersen O, et al. Propagation of oestrogen receptor-positive and oestrogen-responsive normal human breast cells in culture. Nat Commun. 2015;6:8786 pubmed 出版商
  46. Asanoma K, Liu G, Yamane T, Miyanari Y, Takao T, Yagi H, et al. Regulation of the Mechanism of TWIST1 Transcription by BHLHE40 and BHLHE41 in Cancer Cells. Mol Cell Biol. 2015;35:4096-109 pubmed 出版商
  47. Liu J, Brzeszczynska J, Samuel K, Black J, Palakkan A, Anderson R, et al. Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism. Exp Cell Res. 2015;338:203-13 pubmed 出版商
  48. Landa Solís C, Granados Montiel J, Olivos Meza A, Ortega Sánchez C, Cruz Lemini M, Hernández Flores C, et al. Cryopreserved CD90+ cells obtained from mobilized peripheral blood in sheep: a new source of mesenchymal stem cells for preclinical applications. Cell Tissue Bank. 2016;17:137-45 pubmed 出版商
  49. Ducret M, Fabre H, Farges J, Degoul O, Atzeni G, McGuckin C, et al. Production of Human Dental Pulp Cells with a Medicinal Manufacturing Approach. J Endod. 2015;41:1492-9 pubmed 出版商
  50. Wang J, Ma L, Tang X, Zhang X, Qiao Y, Shi Y, et al. Doxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells. Oncotarget. 2015;6:24075-91 pubmed
  51. Takenaka C, Miyajima H, Yoda Y, Imazato H, Yamamoto T, Gomi S, et al. Controlled Growth and the Maintenance of Human Pluripotent Stem Cells by Cultivation with Defined Medium on Extracellular Matrix-Coated Micropatterned Dishes. PLoS ONE. 2015;10:e0129855 pubmed 出版商
  52. James S, Fox J, Afsari F, Lee J, Clough S, Knight C, et al. Multiparameter Analysis of Human Bone Marrow Stromal Cells Identifies Distinct Immunomodulatory and Differentiation-Competent Subtypes. Stem Cell Reports. 2015;4:1004-15 pubmed 出版商
  53. Tsai P, Chang Y, Lee Y, Ko Y, Yang Y, Lin C, et al. Differentiation of blood T cells: Reprogramming human induced pluripotent stem cells into neuronal cells. J Chin Med Assoc. 2015;78:353-9 pubmed 出版商
  54. Tang X, Chen X, Xu Y, Qiao Y, Zhang X, Wang Y, et al. CD166 positively regulates MCAM via inhibition to ubiquitin E3 ligases Smurf1 and βTrCP through PI3K/AKT and c-Raf/MEK/ERK signaling in Bel-7402 hepatocellular carcinoma cells. Cell Signal. 2015;27:1694-702 pubmed 出版商
  55. Zhou H, Martínez H, Sun B, Li A, Zimmer M, Katsanis N, et al. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood. Stem Cell Rev. 2015;11:652-65 pubmed 出版商
  56. Zhang W, Pei Y, Zhong L, Wen B, Cao S, Han J. Pluripotent and Metabolic Features of Two Types of Porcine iPSCs Derived from Defined Mouse and Human ES Cell Culture Conditions. PLoS ONE. 2015;10:e0124562 pubmed 出版商
  57. Zhang P, Yang X, Ma X, Ingram D, Lazar A, Torres K, et al. Antitumor effects of pharmacological EZH2 inhibition on malignant peripheral nerve sheath tumor through the miR-30a and KPNB1 pathway. Mol Cancer. 2015;14:55 pubmed 出版商
  58. Lee D, Su J, Kim H, Chang B, Papatsenko D, Zhao R, et al. Modeling familial cancer with induced pluripotent stem cells. Cell. 2015;161:240-54 pubmed 出版商
  59. Ali H, Al Yatama M, Abu Farha M, Behbehani K, Al Madhoun A. Multi-lineage differentiation of human umbilical cord Wharton's Jelly Mesenchymal Stromal Cells mediates changes in the expression profile of stemness markers. PLoS ONE. 2015;10:e0122465 pubmed 出版商
  60. Narcisi R, Cleary M, Brama P, Hoogduijn M, Tüysüz N, ten Berge D, et al. Long-term expansion, enhanced chondrogenic potential, and suppression of endochondral ossification of adult human MSCs via WNT signaling modulation. Stem Cell Reports. 2015;4:459-72 pubmed 出版商
  61. Caminal M, Peris D, Fonseca C, Barrachina J, Codina D, Rabanal R, et al. Cartilage resurfacing potential of PLGA scaffolds loaded with autologous cells from cartilage, fat, and bone marrow in an ovine model of osteochondral focal defect. Cytotechnology. 2016;68:907-19 pubmed 出版商
  62. Kaushik G, Venugopal A, Ramamoorthy P, Standing D, Subramaniam D, Umar S, et al. Honokiol inhibits melanoma stem cells by targeting notch signaling. Mol Carcinog. 2015;54:1710-21 pubmed 出版商
  63. Johnstone S, Liley M, Dalby M, Barnett S. Comparison of human olfactory and skeletal MSCs using osteogenic nanotopography to demonstrate bone-specific bioactivity of the surfaces. Acta Biomater. 2015;13:266-76 pubmed 出版商
  64. Wilson P, Payne T. Genetic reprogramming of human amniotic cells with episomal vectors: neural rosettes as sentinels in candidate selection for validation assays. Peerj. 2014;2:e668 pubmed 出版商
  65. Byrne S, Ortiz L, Mali P, Aach J, Church G. Multi-kilobase homozygous targeted gene replacement in human induced pluripotent stem cells. Nucleic Acids Res. 2015;43:e21 pubmed 出版商
  66. Shimamoto A, Kagawa H, Zensho K, Sera Y, Kazuki Y, Osaki M, et al. Reprogramming suppresses premature senescence phenotypes of Werner syndrome cells and maintains chromosomal stability over long-term culture. PLoS ONE. 2014;9:e112900 pubmed 出版商
  67. Sako Kubota K, Tanaka N, Nagae S, Meng W, Takeichi M. Minus end-directed motor KIFC3 suppresses E-cadherin degradation by recruiting USP47 to adherens junctions. Mol Biol Cell. 2014;25:3851-60 pubmed 出版商
  68. Tsai H, Deng W, Lai W, Chiu W, Yang C, Tsai Y, et al. Wnts enhance neurotrophin-induced neuronal differentiation in adult bone-marrow-derived mesenchymal stem cells via canonical and noncanonical signaling pathways. PLoS ONE. 2014;9:e104937 pubmed 出版商
  69. Wennerström A, Lothe I, Sandhu V, Kure E, Myklebost O, Munthe E. Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines. PLoS ONE. 2014;9:e103873 pubmed 出版商
  70. Chang Y, Chang W, Hung K, Yang D, Cheng Y, Liao Y, et al. The generation of induced pluripotent stem cells for macular degeneration as a drug screening platform: identification of curcumin as a protective agent for retinal pigment epithelial cells against oxidative stress. Front Aging Neurosci. 2014;6:191 pubmed 出版商
  71. Ma L, Pan Q, Sun F, Yu Y, Wang J. Cluster of differentiation 166 (CD166) regulates cluster of differentiation (CD44) via NF-?B in liver cancer cell line Bel-7402. Biochem Biophys Res Commun. 2014;451:334-8 pubmed 出版商
  72. Ferrer M, Corneo B, Davis J, Wan Q, Miyagishima K, King R, et al. A multiplex high-throughput gene expression assay to simultaneously detect disease and functional markers in induced pluripotent stem cell-derived retinal pigment epithelium. Stem Cells Transl Med. 2014;3:911-22 pubmed 出版商
  73. Muchkaeva I, Dashinimaev E, Artyuhov A, Myagkova E, Vorotelyak E, Yegorov Y, et al. Generation of iPS Cells from Human Hair Follice Dermal Papilla Cells. Acta Naturae. 2014;6:45-53 pubmed
  74. Zhou J, Lu P, Ren H, Zheng Z, Ji J, Liu H, et al. 17?-estradiol protects human eyelid-derived adipose stem cells against cytotoxicity and increases transplanted cell survival in spinal cord injury. J Cell Mol Med. 2014;18:326-43 pubmed 出版商
  75. Weber B, Kehl D, Bleul U, Behr L, Sammut S, Frese L, et al. In vitro fabrication of autologous living tissue-engineered vascular grafts based on prenatally harvested ovine amniotic fluid-derived stem cells. J Tissue Eng Regen Med. 2016;10:52-70 pubmed 出版商
  76. Lv X, Zhou G, Liu Y, Liu X, Chen J, Luo X, et al. In vitro proliferation and differentiation of adipose-derived stem cells isolated using anti-CD105 magnetic beads. Int J Mol Med. 2012;30:826-34 pubmed 出版商